Skip to main content
Top
Published in: Cancer Cell International 1/2003

Open Access 01-12-2003 | Primary research

Epithelial Na, K-ATPase expression is down-regulated in canine prostate cancer; a possible consequence of metabolic transformation in the process of prostate malignancy

Authors: Ali Mobasheri, Richard Fox, Iain Evans, Fay Cullingham, Pablo Martín-Vasallo, Christopher S Foster

Published in: Cancer Cell International | Issue 1/2003

Login to get access

Abstract

Background

An important physiological function of the normal prostate gland is the synthesis and secretion of a citrate rich prostatic fluid. In prostate cancer, citrate production levels are reduced as a result of altered cellular metabolism and bioenergetics. Na, K-ATPase is essential for citrate production since the inward Na+ gradients it generates are utilized for the Na+ dependent uptake of aspartate, a major substrate for citrate synthesis. The objective of this study was to compare the expression of previously identified Na, K-ATPase isoforms in normal canine prostate, benign prostatic hyperplasia (BPH) and prostatic adenocarcinoma (PCa) using immunohistochemistry in order to determine whether reduced citrate levels in PCa are also accompanied by changes in Na, K-ATPase expression.

Results

Expression of Na, K-ATPase α1 and β1 isoforms was observed in the lateral and basolateral plasma membrane domains of prostatic epithelial cells in normal and BPH prostates. Canine kidney was used as positive control for expression of Na, K-ATPase α1 and γ isoforms. The α1 isoform was detected in abundance in prostatic epithelial cells but there was no evidence of α2, α3 or γ subunit expression. In advanced PCa, Na, K-ATPase α1 isoform expression was significantly lower compared to normal and BPH glands. The abundant basolateral immunostaining observed in normal and BPH tissue was significantly attenuated in PCa.

Conclusion

The loss of epithelial structure and function and the transformation of normal epithelial cells to malignant cells in the canine prostate have important implications for cellular metabolism and are accompanied by a down regulation of Na, K-ATPase.
Appendix
Available only for authorised users
Literature
1.
go back to reference Costello LC, Franklin RB: Citrate metabolism of normal and malignant prostate epithelial cells. Urology. 1997, 50: 3-12. 10.1016/S0090-4295(97)00124-6.CrossRefPubMed Costello LC, Franklin RB: Citrate metabolism of normal and malignant prostate epithelial cells. Urology. 1997, 50: 3-12. 10.1016/S0090-4295(97)00124-6.CrossRefPubMed
2.
go back to reference Kavanagh JP: Sodium, potassium, calcium, magnesium, zinc, citrate and chloride content of human prostatic and seminal fluid. J Reprod Fertil. 1985, 75: 35-41.CrossRefPubMed Kavanagh JP: Sodium, potassium, calcium, magnesium, zinc, citrate and chloride content of human prostatic and seminal fluid. J Reprod Fertil. 1985, 75: 35-41.CrossRefPubMed
3.
go back to reference Franklin RB, Lao LX, Costello LC: Evidence for two aspartate transport systems in prostate epithelial cells. Prostate. 1990, 16: 137-45.CrossRefPubMed Franklin RB, Lao LX, Costello LC: Evidence for two aspartate transport systems in prostate epithelial cells. Prostate. 1990, 16: 137-45.CrossRefPubMed
4.
go back to reference Costello LC, Franklin RB: The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy. Oncology. 2000, 59: 269-82. 10.1159/000012183.PubMedCentralCrossRefPubMed Costello LC, Franklin RB: The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy. Oncology. 2000, 59: 269-82. 10.1159/000012183.PubMedCentralCrossRefPubMed
5.
go back to reference Smith ER: The secretion of electrolytes by the pilocarpine-stimulated canine prostate gland. Proc Soc Exp Biol Med. 1969, 132: 223-6.CrossRefPubMed Smith ER: The secretion of electrolytes by the pilocarpine-stimulated canine prostate gland. Proc Soc Exp Biol Med. 1969, 132: 223-6.CrossRefPubMed
6.
go back to reference Farnsworth WE: Androgen regulation of prostatic membrane ATPase. Biol Reprod. 1970, 3: 218-22.PubMed Farnsworth WE: Androgen regulation of prostatic membrane ATPase. Biol Reprod. 1970, 3: 218-22.PubMed
7.
go back to reference Farnsworth WE: Na+, K(+)-ATPase: the actual androgen receptor of the prostate?. Med Hypotheses. 1993, 41: 358-62.CrossRefPubMed Farnsworth WE: Na+, K(+)-ATPase: the actual androgen receptor of the prostate?. Med Hypotheses. 1993, 41: 358-62.CrossRefPubMed
8.
go back to reference Blok LJ, de Ruiter PE, Brinkmann AO: Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding. Biochemistry. 1998, 37: 3850-7. 10.1021/bi9724422.CrossRefPubMed Blok LJ, de Ruiter PE, Brinkmann AO: Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding. Biochemistry. 1998, 37: 3850-7. 10.1021/bi9724422.CrossRefPubMed
9.
go back to reference Blok LJ, Chang GT, Steenbeek-Slotboom M, van Weerden WM, Swarts HG, De Pont JJ, van Steenbrugge GJ, Brinkmann AO: Regulation of expression of Na+, K+-ATPase in androgen-dependent and androgen-independent prostate cancer. Br J Cancer. 1999, 81: 28-36. 10.1038/sj.bjc.6690647.PubMedCentralCrossRefPubMed Blok LJ, Chang GT, Steenbeek-Slotboom M, van Weerden WM, Swarts HG, De Pont JJ, van Steenbrugge GJ, Brinkmann AO: Regulation of expression of Na+, K+-ATPase in androgen-dependent and androgen-independent prostate cancer. Br J Cancer. 1999, 81: 28-36. 10.1038/sj.bjc.6690647.PubMedCentralCrossRefPubMed
10.
go back to reference Blanco G, Mercer RW: Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol. 1998, 275: F633-50.PubMed Blanco G, Mercer RW: Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol. 1998, 275: F633-50.PubMed
11.
go back to reference Mobasheri A, Avila J, Cozar-Castellano I, Brownleader MD, Trevan M, Francis MJ, Lamb JF, Martin-Vasallo P: Na+, K+-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep. 2000, 20: 51-91. 10.1023/A:1005580332144.CrossRefPubMed Mobasheri A, Avila J, Cozar-Castellano I, Brownleader MD, Trevan M, Francis MJ, Lamb JF, Martin-Vasallo P: Na+, K+-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep. 2000, 20: 51-91. 10.1023/A:1005580332144.CrossRefPubMed
12.
go back to reference Scheiner-Bobis G, Meyer zu Heringdorf D, Christ M, Habermann E: Palytoxin induces K+ efflux from yeast cells expressing the mammalian sodium pump. Mol Pharmacol. 1994, 45: 1132-6.PubMed Scheiner-Bobis G, Meyer zu Heringdorf D, Christ M, Habermann E: Palytoxin induces K+ efflux from yeast cells expressing the mammalian sodium pump. Mol Pharmacol. 1994, 45: 1132-6.PubMed
13.
14.
go back to reference Woo AL, James PF, Lingrel JB: Sperm motility is dependent on a unique isoform of the Na, K-ATPase. J Biol Chem. 2000, 275: 20693-9. 10.1074/jbc.M002323200.CrossRefPubMed Woo AL, James PF, Lingrel JB: Sperm motility is dependent on a unique isoform of the Na, K-ATPase. J Biol Chem. 2000, 275: 20693-9. 10.1074/jbc.M002323200.CrossRefPubMed
15.
go back to reference Mercer RW, Biemesderfer D, Bliss DP, Collins JH, Forbush B: Molecular cloning and immunological characterization of the gamma polypeptide, a small protein associated with the Na, K-ATPase. J Cell Biol. 1993, 121: 579-86.CrossRefPubMed Mercer RW, Biemesderfer D, Bliss DP, Collins JH, Forbush B: Molecular cloning and immunological characterization of the gamma polypeptide, a small protein associated with the Na, K-ATPase. J Cell Biol. 1993, 121: 579-86.CrossRefPubMed
16.
go back to reference Beguin P, Wang X, Firsov D, Puoti A, Claeys D, Horisberger JD, Geering K: The gamma subunit is a specific component of the Na, K-ATPase and modulates its transport function. Embo J. 1997, 16: 4250-60. 10.1093/emboj/16.14.4250.PubMedCentralCrossRefPubMed Beguin P, Wang X, Firsov D, Puoti A, Claeys D, Horisberger JD, Geering K: The gamma subunit is a specific component of the Na, K-ATPase and modulates its transport function. Embo J. 1997, 16: 4250-60. 10.1093/emboj/16.14.4250.PubMedCentralCrossRefPubMed
17.
go back to reference Sweadner KJ, Rael E: The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics. 2000, 68: 41-56. 10.1006/geno.2000.6274.CrossRefPubMed Sweadner KJ, Rael E: The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics. 2000, 68: 41-56. 10.1006/geno.2000.6274.CrossRefPubMed
18.
go back to reference Arystarkhova E, Wetzel RK, Asinovski NK, Sweadner KJ: The gamma subunit modulates Na(+) and K(+) affinity of the renal Na, K-ATPase. J Biol Chem. 1999, 274: 33183-5. 10.1074/jbc.274.47.33183.CrossRefPubMed Arystarkhova E, Wetzel RK, Asinovski NK, Sweadner KJ: The gamma subunit modulates Na(+) and K(+) affinity of the renal Na, K-ATPase. J Biol Chem. 1999, 274: 33183-5. 10.1074/jbc.274.47.33183.CrossRefPubMed
19.
go back to reference Kuster B, Shainskaya A, Pu HX, Goldshleger R, Blostein R, Mann M, Karlish SJ: A new variant of the gamma subunit of renal Na, K-ATPase. Identification by mass spectrometry, antibody binding, and expression in cultured cells. J Biol Chem. 2000, 275: 18441-6. 10.1074/jbc.M001411200.CrossRefPubMed Kuster B, Shainskaya A, Pu HX, Goldshleger R, Blostein R, Mann M, Karlish SJ: A new variant of the gamma subunit of renal Na, K-ATPase. Identification by mass spectrometry, antibody binding, and expression in cultured cells. J Biol Chem. 2000, 275: 18441-6. 10.1074/jbc.M001411200.CrossRefPubMed
20.
go back to reference Mobasheri A, Oukrif D, Dawodu SP, Sinha M, Greenwell P, Stewart D, Djamgoz MB, Foster CS, Martin-Vasallo P, Mobasheri R: Isoforms of Na+, K+-ATPase in human prostate; specificity of expression and apical membrane polarization. Histol Histopathol. 2001, 16: 141-54.PubMed Mobasheri A, Oukrif D, Dawodu SP, Sinha M, Greenwell P, Stewart D, Djamgoz MB, Foster CS, Martin-Vasallo P, Mobasheri R: Isoforms of Na+, K+-ATPase in human prostate; specificity of expression and apical membrane polarization. Histol Histopathol. 2001, 16: 141-54.PubMed
21.
go back to reference Choi Y, Dubel SJ, Pacioaiou ML, Omori A, Ito T, Copeland TD, Takahashi M, McEnery MW: Parallel detection of Na, K-ATPase alpha subunit isoforms by pan-specific monoclonal mAb 9A7. Arch Biochem Biophys. 1997, 344: 165-75. 10.1006/abbi.1997.0183.CrossRefPubMed Choi Y, Dubel SJ, Pacioaiou ML, Omori A, Ito T, Copeland TD, Takahashi M, McEnery MW: Parallel detection of Na, K-ATPase alpha subunit isoforms by pan-specific monoclonal mAb 9A7. Arch Biochem Biophys. 1997, 344: 165-75. 10.1006/abbi.1997.0183.CrossRefPubMed
22.
go back to reference Schmidt JD, Gibbons RP, Murphy GP, Bartolucci A: Adjuvant therapy for localized prostate cancer. Cancer. 1993, 71: 1005-13.CrossRefPubMed Schmidt JD, Gibbons RP, Murphy GP, Bartolucci A: Adjuvant therapy for localized prostate cancer. Cancer. 1993, 71: 1005-13.CrossRefPubMed
23.
go back to reference Laniado ME, Lalani EN, Fraser SP, Grimes JA, Bhangal G, Djamgoz MB, Abel PD: Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am J Pathol. 1997, 150: 1213-21.PubMedCentralPubMed Laniado ME, Lalani EN, Fraser SP, Grimes JA, Bhangal G, Djamgoz MB, Abel PD: Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am J Pathol. 1997, 150: 1213-21.PubMedCentralPubMed
24.
go back to reference Smith P, Rhodes NP, Shortland AP, Fraser SP, Djamgoz MB, Ke Y, Foster CS: Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett. 1998, 423: 19-24. 10.1016/S0014-5793(98)00050-7.CrossRefPubMed Smith P, Rhodes NP, Shortland AP, Fraser SP, Djamgoz MB, Ke Y, Foster CS: Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett. 1998, 423: 19-24. 10.1016/S0014-5793(98)00050-7.CrossRefPubMed
25.
go back to reference Foster CS, Cornford P, Forsyth L, Djamgoz MB, Ke Y: The cellular and molecular basis of prostate cancer. BJU Int. 1999, 83: 171-94. 10.1046/j.1464-410x.1999.00954.x.CrossRefPubMed Foster CS, Cornford P, Forsyth L, Djamgoz MB, Ke Y: The cellular and molecular basis of prostate cancer. BJU Int. 1999, 83: 171-94. 10.1046/j.1464-410x.1999.00954.x.CrossRefPubMed
26.
go back to reference Sandstrom PE, Jonsson O, Grankvist K, Henriksson R: Identification of potassium flux pathways and their role in the cytotoxicity of estramustine in human malignant glioma, prostatic carcinoma and pulmonary carcinoma cell lines. Eur J Cancer. 1994, 30A: 1822-6.CrossRefPubMed Sandstrom PE, Jonsson O, Grankvist K, Henriksson R: Identification of potassium flux pathways and their role in the cytotoxicity of estramustine in human malignant glioma, prostatic carcinoma and pulmonary carcinoma cell lines. Eur J Cancer. 1994, 30A: 1822-6.CrossRefPubMed
27.
go back to reference Fraser SP, Ding Y, Liu A, Foster CS, Djamgoz MB: Tetrodotoxin suppresses morphological enhancement of the metastatic MAT-LyLu rat prostate cancer cell line. Cell Tissue Res. 1999, 295: 505-12. 10.1007/s004410051256.CrossRefPubMed Fraser SP, Ding Y, Liu A, Foster CS, Djamgoz MB: Tetrodotoxin suppresses morphological enhancement of the metastatic MAT-LyLu rat prostate cancer cell line. Cell Tissue Res. 1999, 295: 505-12. 10.1007/s004410051256.CrossRefPubMed
28.
go back to reference Abdul M, Hoosein N: Voltage-gated sodium ion channels in prostate cancer: expression and activity. Anticancer Res. 2002, 22: 1727-30.PubMed Abdul M, Hoosein N: Voltage-gated sodium ion channels in prostate cancer: expression and activity. Anticancer Res. 2002, 22: 1727-30.PubMed
29.
go back to reference Djamgoz MBA, Mycielska M, Madeja Z, Fraser SP, Korohoda W: Directional movement of rat prostate cancer cells in direct-current electric field: involvement of voltagegated Na+ channel activity. J Cell Sci. 2001, 114: 2697-705.PubMed Djamgoz MBA, Mycielska M, Madeja Z, Fraser SP, Korohoda W: Directional movement of rat prostate cancer cells in direct-current electric field: involvement of voltagegated Na+ channel activity. J Cell Sci. 2001, 114: 2697-705.PubMed
31.
go back to reference Espineda C, Seligson DB, James Ball W, Rao J, Palotie A, Horvath S, Huang Y, Shi T, Rajasekaran AK: Analysis of the Na, K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer. 2003, 97: 1859-68. 10.1002/cncr.11267.CrossRefPubMed Espineda C, Seligson DB, James Ball W, Rao J, Palotie A, Horvath S, Huang Y, Shi T, Rajasekaran AK: Analysis of the Na, K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer. 2003, 97: 1859-68. 10.1002/cncr.11267.CrossRefPubMed
32.
go back to reference Takeyasu K, Tamkun MM, Renaud KJ, Fambrough DM: Ouabain-sensitive (Na+ + K+)-ATPase activity expressed in mouse L cells by transfection with DNA encoding the alpha-subunit of an avian sodium pump. J Biol Chem. 1988, 263: 4347-54.PubMed Takeyasu K, Tamkun MM, Renaud KJ, Fambrough DM: Ouabain-sensitive (Na+ + K+)-ATPase activity expressed in mouse L cells by transfection with DNA encoding the alpha-subunit of an avian sodium pump. J Biol Chem. 1988, 263: 4347-54.PubMed
33.
go back to reference Gottardi CJ, Caplan MJ: Molecular requirements for the cell-surface expression of multisubunit ion-transporting ATPases. Identification of protein domains that participate in Na, K-ATPase and H, K-ATPase subunit assembly. J Biol Chem. 1993, 268: 14342-7.PubMed Gottardi CJ, Caplan MJ: Molecular requirements for the cell-surface expression of multisubunit ion-transporting ATPases. Identification of protein domains that participate in Na, K-ATPase and H, K-ATPase subunit assembly. J Biol Chem. 1993, 268: 14342-7.PubMed
34.
go back to reference Urayama O, Shutt H, Sweadner KJ: Identification of three isozyme proteins of the catalytic subunit of the Na, K-ATPase in rat brain. J Biol Chem. 1989, 264: 8271-80.PubMed Urayama O, Shutt H, Sweadner KJ: Identification of three isozyme proteins of the catalytic subunit of the Na, K-ATPase in rat brain. J Biol Chem. 1989, 264: 8271-80.PubMed
35.
go back to reference Arystarkhova E, Sweadner KJ: Isoform-specific monoclonal antibodies to Na, K-ATPase alpha subunits. Evidence for a tissue-specific post-translational modification of the alpha subunit. J Biol Chem. 1996, 271: 23407-17. 10.1074/jbc.271.38.23407.CrossRefPubMed Arystarkhova E, Sweadner KJ: Isoform-specific monoclonal antibodies to Na, K-ATPase alpha subunits. Evidence for a tissue-specific post-translational modification of the alpha subunit. J Biol Chem. 1996, 271: 23407-17. 10.1074/jbc.271.38.23407.CrossRefPubMed
36.
go back to reference Gonzalez-Martinez LM, Avila J, Marti E, Lecuona E, Martin-Vasallo P: Expression of the beta-subunit isoforms of the Na, K-ATPase in rat embryo tissues, inner ear and choroid plexus. Biol Cell. 1994, 81: 215-22.CrossRefPubMed Gonzalez-Martinez LM, Avila J, Marti E, Lecuona E, Martin-Vasallo P: Expression of the beta-subunit isoforms of the Na, K-ATPase in rat embryo tissues, inner ear and choroid plexus. Biol Cell. 1994, 81: 215-22.CrossRefPubMed
Metadata
Title
Epithelial Na, K-ATPase expression is down-regulated in canine prostate cancer; a possible consequence of metabolic transformation in the process of prostate malignancy
Authors
Ali Mobasheri
Richard Fox
Iain Evans
Fay Cullingham
Pablo Martín-Vasallo
Christopher S Foster
Publication date
01-12-2003
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2003
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-3-8

Other articles of this Issue 1/2003

Cancer Cell International 1/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine